Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines

Overview of attention for article published in Cancer Cell International, January 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 105 Dimensions

Readers on

mendeley: 100 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

METHOD FOR PRETREATING RELAPSING CANCER

Application WO-2023227592-A1

World Intellectual Property Organisation (WIPO)

METHOD FOR PRETREATING RELAPSING CANCER

Application EP-4282408-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.